CVE-2023-50343: Hcltech Dryice Myxalytics

Medium severity, CVSS 6.5. EPSS: 0.4% chance of exploitation in the next 30 days.

HCL DRYiCE MyXalytics is impacted by an Improper Access Control (Controller APIs) vulnerability. Certain API endpoints are accessible to Customer Admin Users that can allow access to sensitive information about other users.

Affected products

• Hcltech Dryice Myxalytics: version 5.9 only; version 6.0 only; version 6.1 only

Published 2024-01-03. Last modified 2026-06-17.